Cargando…

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study

BACKGROUND: Patients with psoriatic arthritis (PsA) experience functional impairment and reduced quality of life, and thus patient global assessment in PsA is explained mainly by the physical, but also by the psychological, aspect of the disease. To assess the prevalence of minimal disease activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Queiro, Rubén, Cañete, Juan D., Montilla, Carlos, Abad, Miguel, Montoro, María, Gómez, Susana, Cábez, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372277/ https://www.ncbi.nlm.nih.gov/pubmed/28356155 http://dx.doi.org/10.1186/s13075-017-1277-1

Ejemplares similares

Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study
por: Queiro, Ruben, et al.
Publicado: (2020)

The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review
por: Cañete, Juan D., et al.
Publicado: (2020)

Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning
por: Queiro, Rubén, et al.
Publicado: (2022)

A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis
por: Queiro, Rubén, et al.
Publicado: (2021)

Gene Variant in the NF-κB Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease
por: Coto-Segura, Pablo, et al.
Publicado: (2019)

Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning
por: Queiro, Rubén, et al.
Publicado: (2022)

Obesity in psoriatic arthritis: Comparative prevalence and associated factors
por: Queiro, Rubén, et al.
Publicado: (2019)

Commentary: Sex-based medicine in psoriatic arthritis: Lessons learned from machine learning-based prediction models
por: Queiro, Rubén
Publicado: (2022)

Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis
por: Queiro, Rubén, et al.
Publicado: (2022)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
por: Queiro, Rubén, et al.
Publicado: (2023)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis
por: Lubrano, Ennio, et al.
Publicado: (2021)

HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis
por: Queiro, Ruben, et al.
Publicado: (2006)

Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
por: Cañete, Juan D, et al.
Publicado: (2009)

Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study
por: Romero Pérez, Antonio, et al.
Publicado: (2020)

Management of particular clinical situations in psoriatic arthritis: an expert’s recommendation document based on systematic literature review and extended Delphi process
por: García-Vicuña, Rosario, et al.
Publicado: (2021)

Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis
por: Wervers, Kim, et al.
Publicado: (2018)

Measurement properties of the minimal disease activity criteria for psoriatic arthritis
por: Coates, Laura C, et al.
Publicado: (2019)

The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis
por: Queiro, Rubén, et al.
Publicado: (2014)

Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease
por: Queiro, Rubén, et al.
Publicado: (2021)

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
por: Mease, Philip J., et al.
Publicado: (2020)

Psoriatic Arthritis: Pathogenesis and Targeted Therapies
por: Azuaga, Ana Belén, et al.
Publicado: (2023)

Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience
por: Braña, Ignacio, et al.
Publicado: (2023)

Residual inflammation in psoriatic arthritis patients in stable minimal disease activity
por: Macchioni, Pierluigi, et al.
Publicado: (2022)

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
por: Coates, L. C., et al.
Publicado: (2020)

Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
por: Lubrano, Ennio, et al.
Publicado: (2020)

Evaluating standards of care in psoriatic arthritis of the QUANTUM project (qualitative initiative to improve outcomes): results of an accreditation project in Spain
por: García, Emilio Ignacio, et al.
Publicado: (2020)

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status
por: Queiro, Rubén, et al.
Publicado: (2022)

Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey
por: Lim, Irwin, et al.
Publicado: (2021)

Update on Cardiovascular Risk and Obesity in Psoriatic Arthritis
por: Ramírez, Julio, et al.
Publicado: (2021)

National survey of patients with psoriatic arthritis in Spain: disease activity, pharmacological therapy and impact on quality of life
por: Cañete, J D, et al.
Publicado: (2010)

Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis
por: Scriffignano, Silvia, et al.
Publicado: (2023)

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
por: Mease, Philip J, et al.
Publicado: (2017)

Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis
por: Helliwell, Philip, et al.
Publicado: (2014)

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study
por: Luchetti Gentiloni, Michele Maria, et al.
Publicado: (2023)

Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol
por: Canzoni, Marco, et al.
Publicado: (2018)

Measuring Disease Activity in Psoriatic Arthritis
por: Wong, Priscilla C. H., et al.
Publicado: (2012)

Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey
por: Richette, Pascal, et al.
Publicado: (2022)

Clinical Differences between Men and Women with Psoriatic Arthritis: Relevance of the Analysis of Genes and Polymorphisms in the Major Histocompatibility Complex Region and of the Age at Onset of Psoriasis
por: Queiro, Rubén, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a6hhov8m4kguacvksuhcbh0tan